Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Compass Therapeutics (CMPX) Other Gross PP&E Adjustments (2022 - 2026)

Compass Therapeutics' Other Gross PP&E Adjustments history spans 5 years, with the latest figure at -$1.9 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 929.74% to -$1.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.9 million, a 929.74% decrease, with the full-year FY2025 number at -$2.4 million, down 13782.35% from a year prior.
  • Other Gross PP&E Adjustments hit -$1.9 million in Q1 2026 for Compass Therapeutics, up from -$2.4 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for CMPX hit a ceiling of $6.0 million in Q2 2024 and a floor of -$3.1 million in Q2 2025.
  • Historically, Other Gross PP&E Adjustments has averaged $1.9 million across 5 years, with a median of $2.2 million in 2022.
  • Biggest five-year swings in Other Gross PP&E Adjustments: grew 29.29% in 2023 and later tumbled 13782.35% in 2025.
  • Tracing CMPX's Other Gross PP&E Adjustments over 5 years: stood at $4.2 million in 2022, then increased by 29.29% to $5.4 million in 2023, then crashed by 100.32% to -$17000.0 in 2024, then tumbled by 13782.35% to -$2.4 million in 2025, then rose by 18.43% to -$1.9 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for CMPX at -$1.9 million in Q1 2026, -$2.4 million in Q4 2025, and -$2.7 million in Q3 2025.